Literature DB >> 29888992

Advances in rectal drug delivery systems.

Trusha J Purohit1, Sara M Hanning1, Zimei Wu1.   

Abstract

Drug delivery via the rectum is a useful alternative route of administration to the oral route for patients who cannot swallow. Traditional rectal dosage forms have been historically used for localized treatments including delivery of laxatives, treatment of hemorrhoids and for delivery of antipyretics. However, the recent trend is showing an increase in the development of novel rectal delivery systems to deliver drug directly into the systemic circulation by taking advantage of porto-systemic shunting. The present review is based on research studies carried out between years 1969-2017. Data for this review have been derived from keyword searches using Scopus and Medline databases. Novel rectal drug delivery systems including hollow-type suppositories, thermo-responsive and muco-adhesive liquid suppositories, and nanoparticulate systems incorporated into an appropriate vehicle have offered more control over delivery of drug molecules for local or systemic actions. In addition, various methods for in vitro-in vivo evaluation of rectal drug delivery systems are covered which is as important as the formulation, and must be carried out using appropriate methodology. Continuous research and development in this field of drug delivery may unleash the hidden potential of the rectal drug delivery systems.

Entities:  

Keywords:  Rectal drug delivery; double reversible thermo-responsive; hollow-type suppository; liquid suppository; nanoparticles; rectal gel

Mesh:

Substances:

Year:  2018        PMID: 29888992     DOI: 10.1080/10837450.2018.1484766

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  11 in total

Review 1.  Foundations of gastrointestinal-based drug delivery and future developments.

Authors:  Jacqueline N Chu; Giovanni Traverso
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-16       Impact factor: 46.802

2.  Development of Stable Nano-Sized Transfersomes as a Rectal Colloid for Enhanced Delivery of Cannabidiol.

Authors:  Thope Moqejwa; Thashree Marimuthu; Pierre P D Kondiah; Yahya E Choonara
Journal:  Pharmaceutics       Date:  2022-03-25       Impact factor: 6.525

3.  Ascorbyl Palmitate Hydrogel for Local, Intestinal Delivery of Macromolecules.

Authors:  Jinyi Zhai; Julia Mantaj; Driton Vllasaliu
Journal:  Pharmaceutics       Date:  2018-10-15       Impact factor: 6.321

Review 4.  Physiological and Pharmaceutical Considerations for Rectal Drug Formulations.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2019-10-16       Impact factor: 5.810

Review 5.  Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.

Authors:  Jenny K W Lam; Chucky C K Cheung; Michael Y T Chow; Emily Harrop; Susie Lapwood; Stephen I G Barclay; Ian C K Wong
Journal:  Adv Drug Deliv Rev       Date:  2020-11-01       Impact factor: 15.470

6.  Characterisation of rectal amoxicillin (RAMOX) for the treatment of pneumonia in children.

Authors:  Sara M Hanning; Silvia Matiz; Katharina Krasser; Mine Orlu; Cornelius Dodoo; Simon Gaisford; Catherine Tuleu
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

Review 7.  A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method.

Authors:  Vaisnevee Sugumar; Kuan Ping Ang; Ahmed F Alshanon; Gautam Sethi; Phelim Voon Chen Yong; Chung Yeng Looi; Won Fen Wong
Journal:  Pharmaceutics       Date:  2022-07-04       Impact factor: 6.525

Review 8.  Characteristics of Probiotic Preparations and Their Applications.

Authors:  Guangqiang Wang; Yunhui Chen; Yongjun Xia; Xin Song; Lianzhong Ai
Journal:  Foods       Date:  2022-08-16

Review 9.  Achievements in Thermosensitive Gelling Systems for Rectal Administration.

Authors:  Maria Bialik; Marzena Kuras; Marcin Sobczak; Ewa Oledzka
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

10.  Mucoadhesive-to-penetrating controllable peptosomes-in-microspheres co-loaded with anti-miR-31 oligonucleotide and Curcumin for targeted colorectal cancer therapy.

Authors:  Ran Zhao; Sujuan Du; Ying Liu; Cong Lv; Yongli Song; Xinchun Chen; Bing Zhang; Dan Li; Shan Gao; Wei Cui; Maksim V Plikus; Xiaohua Hou; Kaichun Wu; Zhanju Liu; Zhihua Liu; Yingzi Cong; Yuan Li; Zhengquan Yu
Journal:  Theranostics       Date:  2020-02-18       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.